Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Outstanding Common Stock Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive outstanding potential common stock (in shares) | 18,557 | 21,586 |
| Outstanding stock options and unvested RSUs | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive outstanding potential common stock (in shares) | 18,330 | 21,246 |
| Shares of common stock pursuant to ESPP | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive outstanding potential common stock (in shares) | 227 | 340 |